First Time Loading...

Lifecore Biomedical Inc
NASDAQ:LFCR

Watchlist Manager
Lifecore Biomedical Inc Logo
Lifecore Biomedical Inc
NASDAQ:LFCR
Watchlist
Price: 6.39 USD 0.63% Market Closed
Updated: May 6, 2024
Section:
 

Wall Street
Price Targets

LFCR Price Targets Summary
Lifecore Biomedical Inc

Wall Street analysts forecast LFCR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LFCR is 8.16 USD with a low forecast of 6.06 USD and a high forecast of 10.5 USD.

LFCR Lowest Forecast
Wall Street Target
6.06 USD
5% Downside
LFCR Average Forecast
Wall Street Target
8.16 USD
28% Upside
LFCR Highest Forecast
Wall Street Target
10.5 USD
64% Upside
Lowest
Price Target
6.06 USD
5% Downside
Average
Price Target
8.16 USD
28% Upside
Highest
Price Target
10.5 USD
64% Upside
Lifecore Biomedical Inc Competitors:
Price Targets
603711
Xiangpiaopiao Food Co Ltd
20% Upside
T
TFG
Thaifoods Group PCL
5% Upside
AAC
Australian Agricultural Company Ltd
51% Upside
D
DLADY
Dutch Lady Milk Industries Bhd
19% Downside
603711
Xiangpiaopiao Food Co Ltd
20% Upside
T
TFG
Thaifoods Group PCL
5% Upside
AAC
Australian Agricultural Company Ltd
51% Upside
D
DLADY
Dutch Lady Milk Industries Bhd
19% Downside
ZYDUSWELL
Zydus Wellness Ltd
7% Upside
VLS
Valsoia SpA
43% Upside
J
605300
Jiahe Foods Industry Co Ltd
75% Upside

Revenue
Forecast

Revenue Estimate
Lifecore Biomedical Inc

For the last 8 years the compound annual growth rate for Lifecore Biomedical Inc's revenue is -19%. The projected CAGR for the next 3 years is 17%.

-19%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-13%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Lifecore Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Lifecore Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
LFCR intrinsic value, competitors valuation, and company profile.
DCF Valuation
LFCR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LFCR stock valuation using valuation multiples.
Wall Street Estimates
LFCR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LFCR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LFCR's stock price target?
Price Target
8.16 USD

According to Wall Street analysts, the average 1-year price target for LFCR is 8.16 USD with a low forecast of 6.06 USD and a high forecast of 10.5 USD.

What is Lifecore Biomedical Inc's Revenue forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Lifecore Biomedical Inc's revenue is -19%. The projected CAGR for the next 3 years is 17%.

ALPHA SPREAD
Join more than 134,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.